Chaos…a high octane, pre workout rush of Trenbolone base giving 100mg of incredible lifting power in 1 small shot.
Trenbolone Suspension, a non estered androgenic/anabolic steroid, is a potent agonist of androgen receptors and has been extensively used as a muscle growth promoter and hardener. Trenbolone is a progestin and does not convert to estrogen. The effects of Trenbolone Suspension are rapid and evident during a single injection with primal power, insomnia, intense sweating and animalistic aggression (hence its use as a pre workout shot) longer term effects are increased weight gain, improved food conversion efficiency, decreased muscle RNA and DNA concentrations, and decreased free cathepsin D activity in muscle. The half-life of Trenbolone Suspension in circulation 3 hours.
MEG (Propylene Glycol) as a carrier agent offers exceptionally fast delivery of the hormone to the blood stream given MEG’s identical solubility with water. MEG has also been shown to promote site enhancement in specific muscles injected prior to working out. Injecting with a 1/2 inch needle into the target muscle group 1 hour before training exhibits a visible enhancement to the size and shape of the muscle for up to 7 days.
Dosage and administration:
Half life 3 hours
Adult dose (Male) 50-200mg intramuscular injection
Adult dose (Female) 25-50mg intramuscular injection
Average Cycle Length: Indefinite and ongoing since most users will take Chaos as a pre workout shot before each training session
Anabolic #: 500
Androgenic #: 500
Bioavailability: Estimated at 100%
CAS Name: 17-Hydroxyestra-4,9,11-trien-3-one
Synonyms: Tren base, Tren suspension, Trenbolone
This product may crystalize and require reheating before each injection. Small yellow/red 'bubbles' of crystalized hormone may appear at the collar of the vial or leave a yellow film at the bottom of the vial. This is a perfectly normal occurrence and does not effect the product quality, please follow our user guide on how to rescue crashed gear.
|Each ml contains:|
Hematologic: Suppression of clotting factors II, V, VII, and X, bleeding in patients on concomitant anticoagulant therapy, and polycythemia.
Androgens are contraindicated in men with carcinomas of the breast or with known or suspected carcinomas of the prostate and in women who are or may become pregnant.
Genitourinary System in males: